Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ocular Therapeutix (OCUL) Gross Profit (2016 - 2026)

Ocular Therapeutix has reported Gross Profit over the past 13 years, most recently at $9.5 million for Q1 2026.

  • For Q1 2026, Gross Profit rose 374.09% year-over-year to $9.5 million; the TTM value through Mar 2026 reached $34.0 million, up 5.74%, while the annual FY2025 figure was -$2.0 million, 103.39% down from the prior year.
  • Gross Profit for Q1 2026 was $9.5 million at Ocular Therapeutix, up from $293000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $15.9 million in Q4 2024 and troughed at -$21.9 million in Q4 2023.
  • A 5-year average of $6.5 million and a median of $9.5 million in 2026 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: skyrocketed 654.3% in 2022 and later tumbled 267.29% in 2023.
  • Year by year, Gross Profit stood at $13.1 million in 2022, then tumbled by 267.29% to -$21.9 million in 2023, then soared by 172.54% to $15.9 million in 2024, then plummeted by 98.15% to $293000.0 in 2025, then surged by 3127.3% to $9.5 million in 2026.
  • Business Quant data shows Gross Profit for OCUL at $9.5 million in Q1 2026, $293000.0 in Q4 2025, and $12.8 million in Q3 2025.